Stay updated on Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Sign up to get notified when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.

Latest updates to the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The Notice about government funding lapse and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding notice about site operations was added, directing users to cc.nih.gov and opm.gov. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while deletions remove Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No visible changes to study content or details.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations are consolidated under a single Locations heading listing US states and Canadian provinces. The HHS Vulnerability Disclosure entry was removed and the revision version updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check85 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

Stay in the know with updates to Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.